Dihydroxyindanone tyrosine kinase inhibitors

Details Dihydroxyindanone tyrosine kinase inhibitors Dihydroxyindanone tyrosine kinase inhibitors

C - Chemistry, Metallurgy

07

C

C07C 49/747 (2006.01) A61K 31/12 (2006.01) A61K 31/16 (2006.01) A61K 31/38 (2006.01) C07C 45/29 (2006.01) C07C 45/45 (2006.01) C07C 45/67 (2006.01) C07C 45/69 (2006.01) C07C 49/755 (2006.01) C07C 49/83 (2006.01) C07C 49/84 (2006.01) C07C 65/40 (2006.01) C07C 205/45 (2006.01) C07C 233/76 (2006.01) C07C 237/40 (2006.01) C07C 311/21 (2006.01) C07C 311/46 (2006.01) C07C 317/44 (2006.01) C07D 307/46 (2006.01) C07D 333/22 (2006.01) C07F 7/18 (2006.01)

Patent

CA 2109515

2109515 9221641 PCTABS00017 Certain dihydroxyindanone compounds, and their pharmaceutically-acceptable salts, are inhibitors of tyrosine kinase enzymes, and so are useful for the control of tyrosine kinase dependent diseases (e.g. cancer, atherosclerosis).

Affiliated with

Also associated with

Rating

Dihydroxyindanone tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dihydroxyindanone tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydroxyindanone tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1946796